Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003463180 | SCV004199056 | uncertain significance | Familial meningioma | 2023-07-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004654231 | SCV005143655 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-04-19 | criteria provided, single submitter | clinical testing | The p.L539V variant (also known as c.1615C>G), located in coding exon 15 of the NF2 gene, results from a C to G substitution at nucleotide position 1615. The leucine at codon 539 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |